Solara Active Pharma Sciences Limited has informed the Exchange regarding Appointment and Resignation of Chief Executive officer, Appointment and Resignation of Chief Financial Officer, Appointment of a Senior Managerial Personnel.

pdf

Solara Active Pharma Sciences Ltd.

21 Feb 2025

505.65

2.07%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Change in Directorate

BSE India

Solara Active Pharma Sciences has informed the Exchange regarding the appointment of a Managing Director.

pdf

Solara Active Pharma Sciences Ltd.

21 Feb 2025

505.65

2.07%

Corp. Note

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Solara Active Pharma Sciences …

BSE India

Solara Active Pharma Sciences Limited has informed the Exchange regarding Board meeting held on February 21, 2025 interalia to consider Appointment and resignation of MD & CEO, Appointment and resignation of CFO and Appointment of Senior Management Personnel, Reconstitution of Committees, Closure of Wholly owned subsidiary and Grant of ESOP options

pdf

Solara Active Pharma Sciences Ltd.

10 Feb 2025

505.65

2.07%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

BSE India

Monitoring Agency Report for the quarter ended December 31, 2024 received from CRISIL Ratings Limited is being submitted.

pdf

Solara Active Pharma Sciences Ltd.

07 Feb 2025, 10:32AM

505.65

2.07%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

The Company in their Board Committee meeting held today (i.e.) February 07, 2025, considered the proposal to Incorporate a wholly - owned subsidiary Company.

pdf